关节疾病中中酶体干细胞衍生的细胞外囊:治疗效果和潜在机制
Jinhui Wu1, Jiangyi Wu2, Zheng Liu1
1Department of Joint Surgery and Sport Medicine, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, 410000, China.
Journal of orthopaedic translation
|August 22, 2024
概括
介质细胞干细胞衍生的细胞外囊泡 (MSC-EVs) 显示出治疗关节疾病如骨关节炎的前景. 这种无细胞疗法有效促进组织修复和再生,为传统治疗提供了潜在的更安全的替代方案.
科学领域:
- 再生医学是一种再生医学.
- 生物技术是生物技术.
- 整形外科 整形外科 整形外科
背景情况:
- 关节疾病显著损害生活质量和功能.
- 目前用于关节疾病的治疗方法在有效性和安全性方面存在局限性.
- 介酶干细胞衍生的细胞外囊泡 (MSC-EVs) 具有强大的再生能力,免疫性较低.
研究的目的:
- 审查MSC-EVs在各种关节疾病中的治疗潜力.
- 总结MSC-EV在联合维修中的行动机制.
- 讨论基于MSC-EV的疗法和临床翻译的未来方向.
主要方法:
- 在关节疾病中对MSC-EV进行临床前和临床研究的文献综述.
- 报告的治疗效果和潜在的生物机制的分析.
- 讨论临床应用的挑战和机会.
主要成果:
- 在骨关节炎,肌/带损伤,大腿骨头骨硬化和类风湿性关节炎的临床前模型中,MSC-EV显示出显著的治疗效果.
- 通过各种机制,MSC-EVs促进组织再生和修复.
- 基于EVs的疗法为关节疾病治疗提供了一个有前途的无细胞方法.
结论:
- 在一系列关节疾病中,MSC-EV具有相当大的治疗潜力.
- 了解MSC-EV机制对于优化治疗策略至关重要.
- 需要进一步的研究和临床转化才能充分认识到MSC-EV治疗关节疾病的好处.
更多相关视频
07:03Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells
Published on: September 23, 2022
2.0K
09:48Large-Scale Preparation of Synovial Fluid Mesenchymal Stem Cell-Derived Exosomes by 3D Bioreactor Culture
Published on: July 26, 2022
4.3K
相关概念视频
01:19Mesenchymal Stem Cells
4.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K
01:36Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K